🇺🇸 FDA
Pipeline program

imiquimod 5% cream

08US02IMIQ-Rigel

Approved small_molecule completed

Quick answer

imiquimod 5% cream for Actinic Keratoses is a Approved program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
RIGEL PHARMACEUTICALS INC
Indication
Actinic Keratoses
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials